Study indicates interleukin-6-dependant pathway dysregulation as a key druggable feature of COVID-19

Researchers identified an interleukin 6 dependent alternative pathway as a therapeutic strategy against coronavirus disease 2019.

Related Keywords

,Marynaolyak Shutterstock ,Complement Atlas ,Discovery Industry Focus ,Coronavirus Disease Covid 19 ,Covid 19 ,Nterleukin ,Interleukin 6 ,Coronavirus ,Immune System ,Inase ,Phagocytosis ,Protein ,Espiratory ,Cars ,Ars Cov 2 ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Virus ,